-
Dendreon Corporation’s stockholders have witnessed DNDN share price rise and fall over the past several years. Though DNDN shares are currently priced well above its historical lows, many feel that is well below where it should be. Over the years many pundits and serious researchers have written articles in an attempt to identify individuals and institutions who might have manipulated DNDN stock and caused investors to loose millions of dollars and many prostate cancer sufferers to loose their lives. Below is a list of six articles written over the past two years on Dendreon’s share price manipulation:
- Michael Milken, 60,000 Deaths, and the Story of Dendreon – Deep Capture (Sept. 2009)
- CareToLive Writes to Interim FDA Commissioner Dr. Frank Torti – Care to Live (Jan. 2009)
- Steve Cohen, Mafia, Millennium Management and Dendreon – Alex Constantine’s Blacklist (July 2009)
- How Wall Street Hoses Main Street – Wealth Daily (Mar. 2010)
- SEC Declines To Probe Dendreon Conflict Charges – Pharmalot (June 2010)
- Dendreon 69% Plunge Began With Orders to Dump Shares on Market – Bloomberg (April 2009)
Posted in 
Tags: 
